BILAXIN Ophta 6 mg / ml, Augentropfen, Lösung

7680686570023 CH-68657 Augentropfen
BILAXIN Ophta 6 mg / ml, Augentropfen, Lösung
BILAXIN Ophta 6 mg / ml, Augentropfen, Lösung
1 / 2
google

Article details

Package size
5
Selling units
5
Measure
ml
Galenic form
Augentropfen
Galenic group
Augenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/02/2024
Patient information leaflet
Français
01/02/2024
Patient information leaflet
Italien
01/02/2024
Summary of Product Characteristics
Allemand
01/02/2024
Summary of Product Characteristics
Français
01/02/2024
Summary of Product Characteristics
Italien
01/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
6.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

A. Menarini GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
68657
Drug name
BILAXIN Ophta, Augentropfen, Lösung
Galenic form
AUL
ATC Code
S01GX13
Authorization status
Z
Dispensing category
D
First authorization
09/12/2022
Authorization expiration date
08/12/2027
IT Number
11.06.2.
Domain
Human medicine
Field of application
Behandlung der Augensymptome der saisonalen und perennialen allergischen Konjunktivitis bei Erwachsenen

Package details

Description (FR)
BILAXIN Ophta 6 mg / ml gtt opht 6 mg 5 ml
Description (DE)
BILAXIN Ophta 6 mg / ml Trp Opht 6 mg 5 ml
Market launch
15/01/2026
Narcotic (BTM)
No

Other package sizes (1)

BILAXTEN gtt opht 6 mg/ml fl 5 ml
5 ML
GTIN: 7680686570016
View